| Tailoring a specific medical leadership development program for faculty members: the Lyon-Ottawa experience C Falandry, J Bacchetta, M Doret-Dion, C Ferraro-Peyret, CB Confavreux, ... Medical Education Online 29 (1), 2308955, 2024 | 1 | 2024 |
| Liver health in hemophilia in the era of gene therapy Y Dargaud, M Levrero, F Bailly, A Lienhart, F Zoulim Thrombosis Research 240, 109064, 2024 | | 2024 |
| Deciphering the circulating microRNA signature of hemophilic arthropathy A Leuci, M Marano, M Millet, A Lienhart, S Desage, R Chapurlat, ... Thrombosis Research, 109099, 2024 | | 2024 |
| Multicenter evaluation of the hemostatic activity of emicizumab in patients with severe hemophilia A L Josset, A Leuci, M Janbain, A De-Wreede, S Desage, A Lienhart, V Bin, ... Journal of Thrombosis and Haemostasis 22 (7), 1857-1866, 2024 | | 2024 |
| Intérêt d’une démarche de pharmacie clinique au sein des observatoires des traitements des filières de santé maladies rares: exemple de la filière MHEMO L Tourvieilhe, V Chamouard, C Paris, P Saultier, MC Alessi, N Giraud, ... Le Pharmacien Clinicien 59 (2), e161, 2024 | | 2024 |
| Whole F8 gene sequencing identified pathogenic structural variants in the remaining unsolved patients with severe hemophilia A Y Jourdy, N Chatron, M Frétigny, C Zawadzki, A Lienhart, N Stieltjes, ... Journal of Thrombosis and Haemostasis 22 (6), 1616-1626, 2024 | 1 | 2024 |
| Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS) K Fischer, R Lassila, F Peyvandi, A Gatt, SC Gouw, R Hollingsworth, ... Research and practice in thrombosis and haemostasis 8 (4), 102461, 2024 | 1 | 2024 |
| Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B B Tardy‐Poncet, A Montmartin, H Chambost, A Lienhart, B Frotscher, ... Haemophilia 30 (3), 693-701, 2024 | | 2024 |
| The obstetrical consequences of ischemic stroke in women of childbearing age J David, H Desmurs-Clavel, L Mechtouff, A Long, Y Dargaud, J Catella Archives of Gynecology and Obstetrics, 1-8, 2024 | | 2024 |
| " Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery": reply C de Moreuil, Y Dargaud, B Pan-Petesch Journal of thrombosis and haemostasis: JTH 22 (3), 879-880, 2024 | | 2024 |
| Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective W Miesbach, M Carcao, J Mahlangu, Y Dargaud, V Jimenez‐Yuste, ... Haemophilia 30 (2), 257-266, 2024 | 1 | 2024 |
| Comparison of one‐stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII‐Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with … S Désage, C Nougier, S Meunier, V Chamouard, E Jousselme, ... Haemophilia 30 (2), 538-544, 2024 | | 2024 |
| Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding A Leuci, N Enjolras, M Marano, M Daniel, M Brevet, P Connes, Y Dargaud Journal of Thrombosis and Haemostasis 22 (3), 700-708, 2024 | 1 | 2024 |
| Monitoring of albutrepenonacog alpha during invasive procedures in patients with haemophilia B S Desage, C Nougier, V Chamouard, Y Dargaud, S Meunier, A Lienhart HAEMOPHILIA 30, 91-91, 2024 | | 2024 |
| In vitro effect of hydroxyethyl starch on COVID-19 patients–associated hypofibrinolytic state H Rezigue, M Hanss, JS David, Y Dargaud, C Nougier Research and Practice in Thrombosis and Haemostasis 8 (2), 102382, 2024 | | 2024 |
| Stromal cell‐derived factor 1 alpha (SDF‐1alfa) and cartilage oligomeric matrix protein (COMP): Two potential signature biomarkers of radiological detectable hemophilic arthropathy A Leuci, M Robert, L Josset, M Marano, P Connes, S Désage, S Meunier, ... International Journal of Rheumatic Diseases 27 (2), e15061, 2024 | 1 | 2024 |
| Perspectives and perception of haemophilia gene therapy by French patients G Pietu, N Giraud, V Chamouard, G Duport, A Lienhart, Y Dargaud Haemophilia 30 (1), 68-74, 2024 | | 2024 |
| Blood-Induced Arthropathy: A Major Disabling Complication of Haemophilia A Leuci, Y Dargaud Journal of Clinical Medicine 13 (1), 225, 2023 | 3 | 2023 |
| Stromal Cell-Derived Factor 1 Alpha (SDF-1α), Cartilage Oligomeric Matrix Protein (COMP) and Circulating microRNAs 208a-3p and 221-3p: Potential Signature Biomarkers of … A Leuci, M Robert, L Josset, M Marano, P Connes, S Desage, S Meunier, ... Blood 142, 5467, 2023 | | 2023 |
| Low Rebleed Incidence with Eptacog Beta Treatment through 24 and 48 Hours in Children (< 12 years) with Hemophilia a or B with Inhibitors S Pipe, J Oldenburg, M Carcao, M Chitlur, Y Dargaud, J Davis, ... Blood 142, 5480, 2023 | | 2023 |
